Residual antigenicity and its management after removal of vascularized grafts.
Harihara
Y
Y
Department of Surgery, Toranomon Hospital, Tokyo, Japan.
Sanjo
K
K
Otsubo
O
O
Watanabe
G
G
Tsurumaru
M
M
Idezuki
Y
Y
D000818:Animals; D003326:Coronary Circulation; D016572:Cyclosporine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016038:Skin Transplantation / Q000276:immunology*; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
D016572:Cyclosporine